Adiposity and risk of proliferative diseases of the breast prior to the diagnosis of invasive breast cancer: Results from a pilot study

Breast Journal

Volumn 18, Issue 2, 2012, Pages 191-194

  Stahl, Melissa S ^a   Prichard, Jeffrey ^a   Stark, Azadeh ^a  

^a GEISINGER HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ADULT; AGED; BODY MASS; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DISEASE; BREAST HYPERPLASIA; CANCER INVASION; CANCER RISK; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HEALTH INSURANCE; HORMONAL THERAPY; HUMAN; LETTER; MAMMOGRAPHY; OBESITY; PILOT STUDY; POSTMENOPAUSE;

ADIPOSITY; AGE FACTORS; AGED; BODY MASS INDEX; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; HYPERPLASIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PILOT PROJECTS; POSTMENOPAUSE; PREVALENCE; RISK FACTORS;

EID: 84858298407     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2011.01213.x     Document Type: Letter

References (16)

1. Simpson JF,. Update on atypical epithelial hyperplasia and ductal carcinoma in situ. Pathology 2009; 41: 36-39.
2. London SJ, Connolly JL, Schnitt SJ, Colditz GA,. A prospective study of benign breast disease and the risk of breast cancer. JAMA 1992; 267: 941-944.
3. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005; 353: 229-237. (Pubitemid 41058322)
4. Dupont WD, Page DL,. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312: 146-151. (Pubitemid 15192861)
5. Menes TS, Kerlikowske K, Jaffer S, Seger D, Miglioretti DL,. Rates of atypical ductal hyperplasia have declined with less use of postmenopausal hormone treatment: findings from the Breast Cancer Surveillance Consortium. Cancer Epidemiol Biomarkers Prev 2009; 18: 2822-2828.
6. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. 2007.
7. Hankinson SE, Willett WC, Manson JE, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998; 90: 1292-1299. (Pubitemid 28433474)
8. Stark A, Stahl M, Kirchner HL, Krum S, Prichard J, Evans J,. Body mass index at the time of diagnosis and the risk of advanced stages and poorly differentiated cancers of the breast: findings from a case-series study. Int J Obes, 2010; 34: 1381-1386.
9. Stokes ME, Davis CS, Koch GG, (eds). Categorical Data Analysis Using the SAS System, 2nd edn. Cary, NC: SAS Institute Inc., 2000.
10. Schairer C, Hill D, Sturgeon SR, et al. Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2005; 14: 1660-1665. (Pubitemid 40995076)
11. Cui Y, Page DL, Lane DS, Rohan TE,. Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study. Breast Cancer Res Treat 2009; 114: 113-120.
12. Singletary SE,. Rating the risk factors for breast cancer. Ann Surg 2003; 237: 474-482. (Pubitemid 38176426)
13. Haffner SM, Dunn JF, Katz MS,. Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women. Metabolism: Clin Exp 1992; 41: 278-284.
14. Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998; 351: 1393-1396. (Pubitemid 28209997)
15. Kerlikowske K, Miglioretti DL, Buist DS, Walker R, Carney PA, National Cancer Institute-Sponsored Breast Cancer Surveillance, Consortium. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst 2007; 99: 1335-1339. (Pubitemid 47394172)
16. Worsham MJ, Raju U, Lu M, et al. Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat 2009; 118: 1-7.